Pre-IPO Fujian Wanchen Biotechnology Group - The Business Model, Peer Comparison, and the Outlook
WANCHEN's business model relies on economies of scale but faces low profit margin and decreasing growth rate. Valuation compared to BUSY MING...
339 Views
ECM Weekly (22 September 2025)- Chery, Zijin Gold, Orion, Myungin, Urban, Avepoint, Dongfang
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
672 Views
Busy Ming (鸣鸣很忙) Pre-IPO: A Visit to Store – See Young Customers and Busy Clerk
We visited a “Busy for You” store in Shanghai. We believe Busy Ming can attract young customers. However, we also believe the company does not...
509 Views
Pre-IPO Busy Ming Group - Concerns Behind the High Growth
Franchise model benefits BUSY MING with high turnover, but faces risk of homogeneous competition/market oversaturation.Investors may face...
629 Views
ECM Weekly (9 June 2025) - Haitian, Sanhua, Virgin Aus, Primo, Kitazato, Wistron, Kelun Bio, Mao Gep
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
635 Views